Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on “Hepatocellular carcinoma prediction model performance decreases with longterm antiviral therapy in chronic hepatitis B patients”

키워드

참고문헌 (13)

1. Kao JH, "East Asia expert opinion on treatment initiation for chronic hepatitis B", Aliment Pharmacol Ther, 52, pp.1540~1550 (2020)
2. Su TH, "Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients", Liver Int, 36, pp.1755~1764 (2016)
3. Wu X, "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients", Clin Mol Hepatol, 29, pp.747~762 (2023)
4. Wu S, "Comparative performance of 14 HCC prediction models in CHB : A dynamic validation at serial on-treatment timepoints", Am J Gastroenterol, 117, pp.1444~1453 (2022)
5. Papatheodoridis GV, "Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B", J Hepatol, 72, pp.1088~1096 (2020)
6. Nam H, "Prediction of hepatocellular carcinoma by on-therapy response of noninvasive fibrosis markers in chronic hepatitis B", Am J Gastroenterol, 116, pp.1657~1666 (2021)
7. Ha Y, "Fiveyear on-treatment variables-based PPACS model predicts subsequent hepatocellular carcinoma in entecavir", tenofovirtreated patients, 2023, pp.153, 2045~2054
8. Lee JS, "External validation of the FSAC model using on-therapy changes in noninvasive fibrosis markers in patients with chronic hepatitis B : A multicenter study", Cancers(Basel), 14, pp.711~ (2022)
9. Mak LY, "The role of different viral biomarkers on the management of chronic hepatitis B", Clin Mol Hepatol, 29, pp.263~276 (2023)
10. Kim BK, "Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy", J Formos Med Assoc, 122, pp.1238~1246 (2023)
11. Yoo J, "Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection", Clin Mol Hepatol, 29, pp.1029~1042 (2023)
12. Yun B, "Liver cancer risk across metabolic dysfunction-associated steatotic liver disease and", or alcohol : A nationwide study, 2024, ~
13. Yun B, "Association of alcohol consumption with liver cancer and all-cause mortality in chronic hepatitis B patients without cirrhosis", Clin Gastroenterol Hepatol, 21, pp.3191~3194 (2023)

관련 논문AI추천